"Gynecologic Oncology Associates was established in 2007 by Dr. Destin Black who believed that this type of advanced care was needed in the Ark-La-Tex. Her belief was verified as the practice has become widely known for providing unique expertise and compassionate care. Dr. Debra Cline joined the practice in 2014, bringing 17 years of experience in gynecology and colposcopy. Dr. K. Leslie Dean joined in 2018. As surgeons who specialize in the treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers, we pride ourselves on providing superior care to our patients and their families. We use evidence-based practices along with advanced surgical techniques to provide the best possible outcomes."

During the past decade, Willis-Knighton Physician Network Gynecologic Oncology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Willis-Knighton Physician Network Gynecologic Oncology Associates" #1 collaborator was "Genmab" with 1 trials as a collaborator and "Intuitive Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Willis-Knighton Physician Network Gynecologic Oncology Associates" are "Cervical Cancer" (2 trials). Many other conditions were trialed in "Willis-Knighton Physician Network Gynecologic Oncology Associates" in a lesser frequency.

Most popular intervention types in "Willis-Knighton Physician Network Gynecologic Oncology Associates" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "da Vinci" (1 trials), "gemcitabine" (1 trials), "irinotecan" (1 trials), "open surgery" (1 trials) and "pemetrexed" (1 trials). Other intervention names were less common.

The vast majority of trials in "Willis-Knighton Physician Network Gynecologic Oncology Associates" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Willis-Knighton Physician Network Gynecologic Oncology Associates". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Willis-Knighton Physician Network Gynecologic Oncology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Willis-Knighton Physician Network Gynecologic Oncology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".